🇺🇸

Broad Market

· daily

US SEC Filings Daily Market Digest — February 27, 2026

Across 298 SEC filings dated February 27, 2026, a dominant theme is earnings season with 50+ Item 2.02 disclosures (e.g., Amneal Pharma, Cigna, BrightSpring), mostly neutral due to undisclosed metrics, signaling steady but unremarkable Q4/FY2025 results amid quiet markets. Portfolio-level trends show mixed performance: revenues grew YoY in detailed reporters like US Antimony (record highs), Precipio (+30%), American Integrity (+23% premiums), but declined in others like Where Food Comes From (-3.3%), Gogo (ATG aircraft -9%); margins compressed in REITs/hospitality (Apple Hospitality EBITDA -190 bps) while improving in insurance (American Integrity combined ratio -17 ppts). Critical developments include 5 delistings/notices (Datavault AI, reAlpha Tech, Envoy Medical bearish; Sphere 3D regains compliance bullish), $2.8B Netflix termination fee from failed WBD deal, and $200M+ capital raises/debt refinancings (Tandem Diabetes, Ameren $891M bonds, Wyndham $650M notes). M&A activity surged with 20+ Item 1.01 (e.g., Amazon, AIR Industries neutral), insider changes neutral, but positive capital allocation via dividends/buybacks in 15+ (Healthcare Realty $50M repurchases, REIT distributions). Sector patterns favor energy/mining (US Antimony contracts), REITs (guidance intact), but flag biotech delistings and accounting restatements (Elauwit non-reliance). Implications: Favor defensive dividend payers/turnarounds; avoid small-cap delisting risks; monitor Q1 guidance for margin trends.

115 high priority 183 medium 298 total filings
· daily

Global High-Priority Regulatory Events — February 27, 2026

Across 140 filings centered on February 27, 2026, dominant themes include robust debt refinancing and issuance activity (e.g., Wyndham $650M notes, WESCO $1.5B at lower 5.25-5.50% rates vs prior 7.25%), SPAC IPOs and business combinations (e.g., Clearthink $125M, Mozayyx $261M, IQM/RAAQ quantum computing deal), and frequent executive changes/departures (neutral in 20+ cases like Tandem, Iridium, Western New England). Bearish pressures from Nasdaq delisting/deficiency notices (9 cases: Datavault, reAlpha, Envoy, Jupiter, Ensysce, Tenon, CIMG) and insolvencies (10+ medium-risk, mostly Indian firms like Heranba, Reliance). Warner Bros. Discovery's 10-K shows revenue -5% YoY to $37.3B but operating income turnaround from -$10B loss to $738M profit, with Streaming EBITDA +102% to $1.37B; no broad PoP trends but aggregate capital raises exceed $5B+. Media M&A peaks with PSKY $81B WBD takeover (7.5x 2026 EBITDA) and Netflix $2.8B termination fee. Portfolio implication: Favor liquidity-strong firms amid small-cap listing risks; watch Q3 2026 deal closes.

140 high priority 140 total filings
· monthly

US Pre-Market SEC Filings Roundup — February 27, 2026

Across 94 overnight SEC 8-K filings from Feb 26-27, 2026, the dominant theme is a surge in earnings-related disclosures (approx. 40 filings with Item 2.02), signaling peak earnings season with neutral sentiment in all cases due to undisclosed quantitative metrics like YoY/QoQ revenue growth or margins. A notable cluster of 15+ material definitive agreements (Item 1.01) points to heightened M&A activity across sectors like pharma, energy, and tech, potentially indicating consolidation plays though terms remain undisclosed. No insider trading activity, capital allocation details (dividends/buybacks), or forward-looking guidance changes are disclosed in any filing, limiting precise trend synthesis; however, period-over-period comparisons are absent across the board. One critical bearish outlier: Datavault AI Inc. delisting notice (materiality 10/10). Portfolio-level patterns show pharma/biotech (12+ filings) and energy/funds (15+) leading volume, with overall low-medium risk and neutral-to-mixed sentiment implying stable but opaque pre-market positioning. Actionable implication: Monitor exhibits/press releases for hidden beats/misses in high-materiality earnings (avg materiality 6-8/10); M&A clusters offer alpha if accretive.

21 high priority 73 medium 94 total filings